Remdesivir retreatment: another unproven intervention for COVID-19

Detalles Bibliográficos
Autores principales: Al-Heeti, Omar, Kumar, Rebecca N., Kling, Kendall, Angarone, Michael, Achenbach, Chad, Taiwo, Babafemi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8865007/
https://www.ncbi.nlm.nih.gov/pubmed/35022726
http://dx.doi.org/10.1093/jac/dkab472
_version_ 1784655568235921408
author Al-Heeti, Omar
Kumar, Rebecca N.
Kling, Kendall
Angarone, Michael
Achenbach, Chad
Taiwo, Babafemi
author_facet Al-Heeti, Omar
Kumar, Rebecca N.
Kling, Kendall
Angarone, Michael
Achenbach, Chad
Taiwo, Babafemi
author_sort Al-Heeti, Omar
collection PubMed
description
format Online
Article
Text
id pubmed-8865007
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-88650072022-08-17 Remdesivir retreatment: another unproven intervention for COVID-19 Al-Heeti, Omar Kumar, Rebecca N. Kling, Kendall Angarone, Michael Achenbach, Chad Taiwo, Babafemi J Antimicrob Chemother Research Letter Oxford University Press 2022-01-11 /pmc/articles/PMC8865007/ /pubmed/35022726 http://dx.doi.org/10.1093/jac/dkab472 Text en © The Author(s) 2022. Published by Oxford University Press on behalf of British Society for Antimicrobial Chemotherapy. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_modelThis article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model) This article is made available via the PMC Open Access Subset for unrestricted re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the COVID-19 pandemic or until permissions are revoked in writing. Upon expiration of these permissions, PMC is granted a perpetual license to make this article available via PMC and Europe PMC, consistent with existing copyright protections.
spellingShingle Research Letter
Al-Heeti, Omar
Kumar, Rebecca N.
Kling, Kendall
Angarone, Michael
Achenbach, Chad
Taiwo, Babafemi
Remdesivir retreatment: another unproven intervention for COVID-19
title Remdesivir retreatment: another unproven intervention for COVID-19
title_full Remdesivir retreatment: another unproven intervention for COVID-19
title_fullStr Remdesivir retreatment: another unproven intervention for COVID-19
title_full_unstemmed Remdesivir retreatment: another unproven intervention for COVID-19
title_short Remdesivir retreatment: another unproven intervention for COVID-19
title_sort remdesivir retreatment: another unproven intervention for covid-19
topic Research Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8865007/
https://www.ncbi.nlm.nih.gov/pubmed/35022726
http://dx.doi.org/10.1093/jac/dkab472
work_keys_str_mv AT alheetiomar remdesivirretreatmentanotherunproveninterventionforcovid19
AT kumarrebeccan remdesivirretreatmentanotherunproveninterventionforcovid19
AT klingkendall remdesivirretreatmentanotherunproveninterventionforcovid19
AT angaronemichael remdesivirretreatmentanotherunproveninterventionforcovid19
AT achenbachchad remdesivirretreatmentanotherunproveninterventionforcovid19
AT taiwobabafemi remdesivirretreatmentanotherunproveninterventionforcovid19

Ejemplares similares